These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37056784)

  • 1. Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody.
    Bai Y; Li W; Yan C; Hou Y; Wang Q
    Front Immunol; 2023; 14():1121705. PubMed ID: 37056784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: Autoimmune nodopathy with concurrent serum and CSF IgG4 anti-neurofascin 155 antibodies.
    Wang W; Liu L; Zhang M; Yang R; Liu D; Yang S; Meng Q
    Front Immunol; 2022; 13():1028282. PubMed ID: 36248836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical profile of autoimmune nodopathy with anti-neurofascin 186 antibody.
    Liu B; Zhou L; Sun C; Wang L; Zheng Y; Hu B; Qiao K; Zhao C; Lu J; Lin J
    Ann Clin Transl Neurol; 2023 Jun; 10(6):944-952. PubMed ID: 37060203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
    Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
    Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Features of Autoimmune Nodopathy With Anti-Neurofascin-155 Antibodies in South Koreans.
    Lyou HJ; Chung YH; Kim MJ; Kim M; Jeon MY; Kim SW; Shin HY; Kim BJ
    J Clin Neurol; 2024 Mar; 20(2):186-193. PubMed ID: 38171501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies.
    Ren Y; Chen S; Yang H
    Front Immunol; 2023; 14():1279808. PubMed ID: 37965304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy.
    Kmezic I; Press R; Glenewinkel H; Doppler K; Appeltshauser L
    J Neuroimmunol; 2024 Apr; 389():578326. PubMed ID: 38422690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy.
    Wang L; Pan J; Meng H; Yang Z; Zeng L; Liu J
    Brain Sci; 2022 Nov; 12(11):. PubMed ID: 36421911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features of anti-neurofascin-155 antibody positive autoimmune nodopathy in 6 children].
    Fang ZX; Zhang M; Hu CP; Zhou YF; Zhang YJ; Yu LF; Wang Y; Zhou SZ
    Zhonghua Er Ke Za Zhi; 2024 Aug; 62(8):780-785. PubMed ID: 39039882
    [No Abstract]   [Full Text] [Related]  

  • 10. Proteinuria is a key to suspect autoimmune nodopathies.
    Funakoshi K; Kokubun N; Suzuki K; Yuki N
    Eur J Neurol; 2024 Oct; 31(10):e16406. PubMed ID: 38980226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
    Shelly S; Klein CJ; Dyck PJB; Paul P; Mauermann ML; Berini SE; Howe B; Fryer JP; Basal E; Bakri HM; Laughlin RS; McKeon A; Pittock SJ; Mills J; Dubey D
    Neurology; 2021 Dec; 97(24):e2392-e2403. PubMed ID: 34635556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
    Martín-Aguilar L; Lleixà C; Pascual-Goñi E; Caballero-Ávila M; Martínez-Martínez L; Díaz-Manera J; Rojas-García R; Cortés-Vicente E; Turon-Sans J; de Luna N; Suárez-Calvet X; Gallardo E; Rajabally Y; Scotton S; Jacobs BC; Baars A; Cortese A; Vegezzi E; Höftberger R; Zimprich F; Roesler C; Nobile-Orazio E; Liberatore G; Hiew FL; Martínez-Piñeiro A; Carvajal A; Piñar-Morales R; Usón-Martín M; Albertí O; López-Pérez MÁ; Márquez F; Pardo-Fernández J; Muñoz-Delgado L; Cabrera-Serrano M; Ortiz N; Bartolomé M; Duman Ö; Bril V; Segura-Chávez D; Pitarokoili K; Steen C; Illa I; Querol L
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34728497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy.
    Zhang L; Zhang Y; Li R; Zhu J; Lin A; Yan Y; Zhang Z; Wang N; Xu G; Fu Y
    J Neurol; 2024 Aug; 271(8):4991-5002. PubMed ID: 38771386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy.
    Tan CY; Goh KJ; Oh AW; Devaux J; Shahrizaila N
    Neuromuscul Disord; 2022 Mar; 32(3):255-262. PubMed ID: 35183410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody.
    Hou Y; Zhang C; Yu X; Wang W; Zhang D; Bai Y; Yan C; Ma L; Li A; Ji J; Cao L; Wang Q
    Front Immunol; 2022; 13():939062. PubMed ID: 35958552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Fujita A; Ogata H; Yamasaki R; Matsushita T; Kira JI
    J Neurol Sci; 2018 Jan; 384():107-112. PubMed ID: 29249367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of patients with autoimmune nodopathy with anti-neurofascin155 antibodies.
    Zhang J; Hou X; Wei L; Liu J; Li S; Guo Y; Liu H; Jiang Y
    Front Immunol; 2024; 15():1345953. PubMed ID: 38726012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
    Devaux JJ; Miura Y; Fukami Y; Inoue T; Manso C; Belghazi M; Sekiguchi K; Kokubun N; Ichikawa H; Wong AH; Yuki N
    Neurology; 2016 Mar; 86(9):800-7. PubMed ID: 26843559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and diagnostic features of anti-neurofascin-155 antibody-positive neuropathy in Han Chinese.
    Wang W; Liu C; Li W; Zhang D; Shan Y; Zheng J; Shan J; Zhao Y; Yan C; Wang Q
    Ann Clin Transl Neurol; 2022 May; 9(5):695-706. PubMed ID: 35313093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful autologous hematopoietic stem cell transplantation in a refractory anti-Caspr1 antibody nodopathy.
    Afanasiev V; Tsouni P; Kuntzer T; Cairoli A; Delmont E; Vallat JM; Devaux J; Théaudin M
    J Peripher Nerv Syst; 2024 Mar; 29(1):116-119. PubMed ID: 38123899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.